Castleark Management LLC Blueprint Medicines Corp Transaction History
Castleark Management LLC
- $2.41 Billion
- Q3 2024
A detailed history of Castleark Management LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Castleark Management LLC holds 33,990 shares of BPMC stock, worth $3.82 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
33,990
Previous 39,440
13.82%
Holding current value
$3.82 Million
Previous $4.25 Million
26.07%
% of portfolio
0.13%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
355Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$752 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$748 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$606 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$446 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$311 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.72B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...